IDH1 and astrocytoma (excluding glioblastoma): However, only in grade II astrocytoma when comparing the PSS’s predicting accuracy with that of individual parameters of PSS (IDH1 mutational status) was a significant improvement demonstrated and 93.8% accuracy reached.